The chief operating officer (COO) of image-guided radiation therapy vendor ViewRay is leaving the company effective March 31.
Shahriar Matin is leaving his position with ViewRay to become chief executive officer of Cordis following its divestiture from Cardinal Health to the private equity firm Hellman & Friedman.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
